SCHEMBL2179804

SCHEMBL2179804

COc1ccc2cc(-c3ccnc(NC4CCN(C)CC4)n3)cc(N3CCNCC3)c2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 7/20 0.50
MKNK1 Q9BUB5 3/20 0.50
EIF2AK2 P19525 1/20 0.47
NCF1 P14598 1/20 0.47
RET P07949 1/20 0.45
MKNK2 Q9HBH9 1/20 0.45
MAPK8 P45983 3/20 0.43
CDK4 P11802 3/20 0.43
CCND1 P24385 3/20 0.43
CDK1 P06493 2/20 0.43
CCNB1 P14635 2/20 0.43
CCNA2 P20248 2/20 0.43
CDK2 P24941 2/20 0.43
CCNA1 P78396 2/20 0.43
KCNH2 Q12809 1/20 0.43
CCND3 P30281 2/20 0.42
CDK6 Q00534 2/20 0.42
MAPK9 P45984 1/20 0.42
MAPK10 P53779 1/20 0.42
EHMT1 Q9H9B1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2179121 0.90 IKBKB (0.53) IKBKBMKNK1EIF2AK2RETMAPK8
SCHEMBL2176497 0.87 NCF1 (0.45) IKBKBMKNK1EIF2AK2NCF1MKNK2
SCHEMBL2179908 0.87 ACHE (0.54) MKNK1EIF2AK2MKNK2
SCHEMBL2176027 0.85 NCF1 (0.54) IKBKBMKNK1NCF1CCNA2CDK2
SCHEMBL2178908 0.84 EIF2AK2 (0.45) IKBKBMKNK1EIF2AK2NCF1MKNK2
Hydrochloric Acid SCHEMBL2177589 0.84 NCF1 (0.53) IKBKBMKNK1NCF1CCNA2CDK2
SCHEMBL2182169 0.81 DYRK1A (0.53) IKBKBMKNK1NCF1CDK2MAPK9
SCHEMBL2175103 0.80 NCF1 (0.48) IKBKBMKNK1EIF2AK2NCF1CCNA2
SCHEMBL6126567 0.80 IKBKB (0.48) IKBKBMKNK1EIF2AK2RETMAPK8
SCHEMBL2179096 0.80 MKNK1 (0.47) IKBKBMKNK1NCF1MKNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US claimed
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
WO-2011082268-A2 SUBSTITUTED NAPHTHALENYL-PYRIMIDINE COMPOUNDS ARQULE INC. (US) 2011-07-07 WO disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds DPYD, TP53, TYMP IKBKB 401/4885MKNK1 2469/4885EIF2AK2 1269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.